Medical Posters

RSS

Using mass spectrometry chemoproteomics to advance covalent drug development

Using mass spectrometry chemoproteomics to advance covalent drug development

Explore how advanced mass spectrometry-based chemoproteomics streamlines covalent drug discovery.

From Momentum Biotechnologies 28 Oct 2025

In silico development of a multi-epitope vaccine for Pseudomonas aeruginosa

In silico development of a multi-epitope vaccine for Pseudomonas aeruginosa

Discover how computational immunology tools were used to design a multi-epitope vaccine targeting multidrug-resistant Pseudomonas aeruginosa.

From NIPER Hyderabad 28 Oct 2025

Weighing up the benefits of droplet and split-pool single-cell CRISPR screening

Weighing up the benefits of droplet and split-pool single-cell CRISPR screening

Explore the strengths and limitations of two major single-cell CRISPR screening platforms.

From Cellecta, Inc. 28 Oct 2025

Comprehensive T-cell receptor and antigen profiling for immunotherapy discovery

Comprehensive T-cell receptor and antigen profiling for immunotherapy discovery

This platform integrates discovery, profiling, and validation tools to link T-cell receptor diversity with antigen specificity.

From Cellecta, Inc. 28 Oct 2025

Using spatial biology to evaluate a photodynamic therapeutic in melanoma

Using spatial biology to evaluate a photodynamic therapeutic in melanoma

How spatial biology helps in the detailed analysis of immune cell interactions and tissue response in melanoma models.

From Medicines Discovery Catapult 28 Oct 2025

Blocking immune migration with a therapeutic antibody in an in vitro tumor model

Blocking immune migration with a therapeutic antibody in an in vitro tumor model

Learn how antibody-based inhibition of target-mediated immune migration reveals mechanisms driving immune suppression within the tumor microenvironment.

From Mimetas B.V. 28 Oct 2025

Efficient immune receptor chain pairing and cell phenotyping in 96-well plates

Efficient immune receptor chain pairing and cell phenotyping in 96-well plates

A streamlined 96-well plate method unites immune receptor chain pairing and T/B cell immunophenotyping.

From Cellecta, Inc. 28 Oct 2025

Comparative assessment of DCA Vantage and Atellica DCA HbA1c Dx assays

Comparative assessment of DCA Vantage and Atellica DCA HbA1c Dx assays

Discover how the DCA Vantage and Atellica DCA HbA1c Dx assays measure up against the European reference laboratory method.

From Siemens Healthineers 14 Aug 2025

Streamline screening using automated microbial plating

Streamline screening using automated microbial plating

Explore the QPix FLEX for automated microbial plating and picking for streamlined screening.

From Molecular Devices UK Ltd 17 Jul 2025

How multi-laser picodroplet technology can help with single cell analysis

How multi-laser picodroplet technology can help with single cell analysis

Discover how multi-laser picodroplet is a critical tool for high-throughput single cell analysis.

From Fluidic Sciences and Sphere Bio 5 Jun 2025

Scalable human iPSC-derived retinal organoids for in vitro toxicology

Scalable human iPSC-derived retinal organoids for in vitro toxicology

With rising cases of untreatable retinal degeneration, there's a critical need for human-relevant retinal organoid models.

From Newcells Biotech 28 Mar 2025

Scalable human iPSC retinal organoids

Scalable human iPSC retinal organoids

Retinal organoids offer powerful insights into vision science and drug discovery.

From Newcells Biotech 28 Mar 2025

Advancing in vitro assays to model fibroblast-to-myofibroblast transition in fibrosis

Advancing in vitro assays to model fibroblast-to-myofibroblast transition in fibrosis

This study addresses technical challenges in modeling TGF-β1-induced fibroblast activation and FMT in vitro.

From Newcells Biotech 28 Mar 2025

Modeling EMT and FMT in lung fibrosis using high-content imaging for drug discovery

Modeling EMT and FMT in lung fibrosis using high-content imaging for drug discovery

Explore how high-content imaging enables in vitro modeling of key fibrotic processes—EMT and FMT—in lung disease.

From Newcells Biotech 28 Mar 2025

High-content imaging assay for fibroblast activation and matrix deposition in pulmonary fibrosis

High-content imaging assay for fibroblast activation and matrix deposition in pulmonary fibrosis

This in vitro assay models key features of idiopathic pulmonary fibrosis (IPF), including fibroblast activation and ECM deposition.

From Newcells Biotech 28 Mar 2025

High-content imaging enables in vitro modeling of lung fibrosis for anti-fibrotic drug discovery

High-content imaging enables in vitro modeling of lung fibrosis for anti-fibrotic drug discovery

Chronic epithelial injury and TGF-β1-driven fibroblast-to-myofibroblast transition contribute to lung fibrosis.

From Newcells Biotech 28 Mar 2025

In vitro modeling of small airway epithelium for studying barrier function and mucociliary clearance

In vitro modeling of small airway epithelium for studying barrier function and mucociliary clearance

Small airways are critical in respiratory defense and disease but remain hard to study in vivo.

From Newcells Biotech 28 Mar 2025

Evaluating consistency in large-scale human iPSC retinal organoids

Evaluating consistency in large-scale human iPSC retinal organoids

To overcome limitations of current retinal models, discover gene and protein marker expression in large-scale human iPSC-derived retinal organoids.

From Newcells Biotech 28 Mar 2025

Novel fluoroquinolone analogs as anticancer agents

Novel fluoroquinolone analogs as anticancer agents

Explore the development of novel fluoroquinolone analogs as potential anticancer agents, with a focus on their synthesis and biological evaluation.

From Ulster University 14 Nov 2024

MRC-AZ-University of Cambridge joint functional genomics screening laboratory

MRC-AZ-University of Cambridge joint functional genomics screening laboratory

Discover cutting-edge research in genomics, advanced screening techniques, and collaborative innovation in biomedical science.

From AstraZeneca 7 Nov 2024

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.